Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience.
Kandus
A
A
Department of Nephrology, University Medical Centre, Ljubljana, Slovenia.
Kovac
D
D
Cerne
D
D
Koselj
M
M
Kaplan-Pavlovcic
S
S
Buturović
J
J
Ponikvar
R
R
Kveder
R
R
Lindic
J
J
Bren
A F
AF
D000328:Adult; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004576:Electromyography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008148:Lovastatin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012206:Rhabdomyolysis / Q000139:chemically induced
D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D002784:Cholesterol; D008148:Lovastatin